Intrinsic Value of S&P & Nasdaq Contact Us

Daxor Corporation DXR NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
89/100
6/7 Pass
SharesGrow Intrinsic Value
$39.98
+326.2%
Analyst Price Target
$23.00
+145.2%

Daxor Corporation (DXR) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Oak Ridge, TN, United States. The current CEO is Michael Richard Feldschuh.

DXR has IPO date of 1983-07-25, 37 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $47.26M.

About Daxor Corporation

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

📍 109 Meco Lane, Oak Ridge, TN 37830 📞 12123308500
Company Details
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryUnited States
ExchangeNASDAQ Capital Marke
CurrencyUSD
IPO Date1983-07-25
CEOMichael Richard Feldschuh
Employees37
Trading Info
Current Price$9.38
Market Cap$47.26M
52-Week Range7.1-14.76
Beta0.14
ETFNo
ADRNo
CUSIP239467103
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message